Medtech Market Intelligence

To succeed in medtech, you need to have your finger on the pulse – but accurate, reliable information is not always easy to find. We can help you get what you need.

Fast growth in the medical technology market is driven by innovation, demographic shifts, cost-efficient development and increased M&A activity. Success in this arena depends on your ability to bring cutting-edge solutions to the fore quickly, and having accurate intelligence is crucial for a sound development strategy.

How we help

Our medtech market intelligence will keep you up-to-date with important events and help you anticipate future technology needs – so you can evaluate new market opportunities and make confident business decisions.

Find comprehensive and accurate information on devices/diagnostics that compete in your markets
Stay abreast of important current events in our space that will affect your business
Rapidly find information on opportunities or targets within the medtech arena
Stay up to date with new trends and innovation in order to evaluate opportunities as they arise

Medtech Insight

US FDA-Sponsored Cybersecurity Threat Modeling Playbook Tries To Make It Simple

By Ferdous Al-Faruque 30 Nov 2021

The MITRE corporation and MDIC have produced a manual on how to use cybersecurity threat modeling to make safer medical devices. The document asks four basic questions and provides helpful examples.

Medtech Insight

Exec Chat: CMR Surgical Prepares For Intensifying Competition In RAS

By Barnaby Pickering 30 Nov 2021

In an interview with Medtech Insight, Per Vegard Nerserth, CEO of CMR Surgical, discusses how the company adapted to the pandemic, its future plans, and how the competition for market dominance is shaping up.

In Vivo

How Will Pfizer Leverage External Innovation After BioNTech Jackpot?

By Lucie Ellis-Taitt 22 Nov 2021

Uwe Schoenbeck, CSO of external science and innovation at Pfizer, knows the company set itself a high bar during the COVID-19 pandemic after rapidly bringing a breakthrough vaccine to market. While the circumstances for the development of Comirnaty were truly unique, Pfizer does not expect to rest on its laurels when it comes to innovative R&D.

In Vivo

A New Generation Invents Pharma’s Mirrored Future

By Joanne Shorthouse 17 Nov 2021

Young businesses are getting set to disrupt every inch of the healthcare space with digital twin technology. Outlook spoke to two startups on the brink of a data dawn.

Medtech Insight

Leading Medtech CEOs Say Health Equity, Environmental Work Will Outlast Pandemic

By Marion Webb 02 Nov 2021

The medtech sector’s drive to create a fairer health care system and a greener world will go on after the COVID pandemic, which has brought such issues into sharp relief. CEOs at leading companies discuss environmental, social and governance imperatives for their companies and the larger industry.

Medtech Insight

Former US FDA Commish Califf Endorses ‘Tortoise’ Approach To Clinical Trials

By Brenda Sandburg 02 Nov 2021

The once and likely future FDA commissioner emphasized the value of randomized controlled trials, the fact that not all trials are good for people, and how decentralization and digitization are leaving people behind during a panel discussion.

In Vivo

Optimism About Alzheimer’s Disease: Gene Therapy, Digital Therapeutics And New Biomarkers

By Ben Comer 14 Oct 2021

Experts in drug development, clinical care and digital therapeutics discuss gaps in the treatment landscape for Alzheimer’s disease, as well as opportunities for prevention and innovation in care delivery.

Medtech Insight

Digital Health Roundup, August/September 2021: Record Digital Health Funding Q1-3 Of $21.3Bn, AAOS Highlights, Regulatory Updates

By Marion Webb 12 Oct 2021

In this roundup of developments in digital health, we highlight the key news and announcements from August and September.

Medtech Insight

Medtech Companies Face Challenges And Choices When Going Public

By Barnaby Pickering 12 Oct 2021

In a panel discussion at The Medtech Conference, hosted by AdvaMed, CEOs discussed the challenges, benefits and technicalities surrounding an IPO.

In Vivo

In Vivo Outlook 2021 Report

08 Oct 2021

The highly anticipated Outlook 2022 report from Informa Pharma Intelligence is coming soon. Reach the thousands of senior decision makers who eagerly await this pharma industry ranking and review for the year ahead, with sponsorship opportunities that align your brand with our trusted information.

Medtech Insight

CMS Dashes Industry Hopes For MCIT Rule Any Time Soon

By Ferdous Al-Faruque 14 Sep 2021

The US Medicare agency has proposed to withdraw a rule that would give temporary automatic coverage to breakthrough devices, stating the rule doesn’t meet its evidence threshold and could put patients at risk.

Medtech Insight

Industry Needs Direction And Support As Notified Body Powers Strengthen

By Amanda Maxwell 14 Sep 2021

Gone are the days when notified bodies needed to promote themselves to gain business. Now industry is left struggling to find services ̶ and the EU regulatory outlook is becoming worrisome.

In Vivo

How Should Opioid Settlement Dollars Be Spent? It’s Complicated

By Ben Comer 07 Sep 2021

Treating opioid addiction successfully requires an individualized approach, and a lot of money. Executives at addiction treatment centers discuss existing barriers in the recovery pathway and the need to destigmatize addiction and mental health disorders.

Biomedtracker, Meddevicetracker

Q3 2021 Outlook Report

27 Aug 2021

What major drug catalysts and events can you expect to see in the months ahead? Download your free extract from the Q3 2021 Outlook Report and infographic to find out. Shape your strategy with your inside look at what’s to come.